The results indicate that AITC decreased the levels of myeloid cell lymphoma-1 (MCL-1), matrix metalloproteinase-9 (MMP-9), vascular endothelial growth factor (VEGF), and X-linked inhibitor of apoptosis (XIAP) (Figure 5), and increased the expression of caspase-3, -8, and -9 in tumor sections (Figure 5). The gene discussed is MCL1; the disease is neoplasm.